, L'interleukine 2 en immunothérapie clinique

, ASSIM. Immunologie clinique, 1992.

G. Medsi-/-mc, , 1990.

B. Lesavre-p,

. Immunologie, Collection de la biologie à la clinique -Médecine -Sciences

. Flammarion, , 1989.

B. A. Chabner, Pharmacologie Principles of cancer treatment

W. B. Saunders and . Philadelphia, , 1982.

B. A. Chabner, Cancer chemotherapy and biological response modifiers, 1988.

M. Clavel and . Cativel-g,

, Vomissements anticipés et impératif d'efficacité sur l'émésis dès la première cure de chimiothérapie

, Collection Z chimio, 1991.

G. J. Bobin and J. Y. Clavel-m,

. Cancérologie-pour-le-praticien,

S. A. Simep, , 1986.

G. Mathe and G. Meyniel-g, Pharmacologie clinique, bases de la thérapeutique -2ème édition. Expansion Scientifique Française, 1988.

. Hoerni-b, Encyclopédie des cancers-Flammarion médecine-sciences, 1986. HOERNI B. Le médecin généraliste face aux cancers, 1988.

T. Hoerni, . Jacquillat-cl, D. Khayat, . Weil-u, . R. Band-p et al., Encyclopédie des cancers -Flammarion médecine-sciences, CANCERS Guide clinique, 1986.

. Koukay-n,

, Rôle du zinc et du sélénium dans la génération des radicaux libres lors des accidents ischémiques du myocarde

P. Machy and . Leserman-l,

, Les liposomes en biologie cellulaire et pharmacologie. Collection : Recherches en-Editions INSERM, 1987.

G. Powis and . Hacker-m.-p,

-. Hawthorn-j, Encyclopédie des cancers -Flammarion Médecine sciences, 1986.

, Bailliere's Clinical Gastroenterology, vol.2, pp.141-168, 1988.

, Liposomes as Carrier of Mèthyl-GAG, lncreased Antitumor Activity and Reduced Hypoglycemia in Mice

, Oncology, vol.44, issue.4, pp.257-262, 1987.

. Baines-m, . J. Oliver-d, . L. Carter-r, . W. ;--baldwin-r, M. J. Embleton et al., Medical management of intestinal obstruction in patients with advanced malignant disease. A clinical and pathology study, Lancet, vol.2, issue.4, pp.990-993, 1985.

, Monoclonal Antitumor Antibodies for Tumour Detection and Therapy. Behring lnst. Mitt, vol.74, pp.3-13, 1984.

P. Bienvenu, . Caron-l, D. Gasparutto, and . Kergonou-j.-f,

, Assessing and counteracting the proxidant effects of anticancer drugs

-. D. Sharkey-r and . M. Goldenberg-d, Current perspectives and challenges in the use of monoclonal antibodies as imaging and therapeutic agents, pp.257-265, 1992.

, Advanced Drug Delivery Reviews, vol.1, pp.279-318, 1990.

, Scientists Mobilize To lncrease Supply of Anticancer Drug Taxol. News, vol.2, pp.11-18, 1991.

B. ,

, Les nouveaux traitements anti-prolifératifs

L. Gazette-médicale, , pp.13-18, 1992.

P. Casellas, . J. Buurie-b, . Gros-p, and . K. Jansen-f, Kinetics of cytotoxicity induced by immunotoxins. Enhancement by lysosomotropic amines and carboxylic ionospheres

, J. Biol. chem, vol.259, pp.9359-9364, 1984.

. R. Cassileth-b, . J. Lusk-e, and T. B. Strouse, Psychosocial status in chronic illness. A comparative analysis of six diagnostic g roups

, New Engl. J. Med, vol.311, pp.506-511, 1984.

-. W. Omalley-b, Mechanism of action of the steroid hormones

, 12 -CHANG T. M. Induction chemotherapy for advanced head and neck cancers: a literature review. Head and neck surgery, New Engl. J. Med, vol.294, pp.150-159, 1322.

-. Peltier-p, M. Bardies, . Chetanneau-a, P. Thedrez, . Faivre-chauvet-a et al.,

, Does immunoscintigraphy serve clinical needs effectively? ls there a future for radioimmunotherapy ?, Eur. J. Nucl. Med, vol.2, pp.205-213, 1992.

M. Cicardi, M. Cardinal, G. Bisiani, . Rosti-a, and P. Allavena, The systemic capillary leak syndrome: Appearance of interleukin -2 receptor positive cells during attachs

, Ann. Inter. Med, vol.113, pp.475-477, 1990.

-. M. Connor-t and . R. Stevens-k, Occupational exposure of nursing personnel to antineoplastic agents

, Oncology Nursing Forum, vol.12, pp.33-39, 1985.

-. and A. S. Kayes, On the receiving end-patient perception of the side-effects of cancer chemothera py

, Eur. J. Cancer Clin. Oncol, vol.12, pp.203-208, 1983.

-. ,

, La biologie moléculaire en cancérologie (Il) -Implications pratiques. Le généraliste, vol.1329, pp.10-14, 1992.

-. Mouhieddine, S. J. Richard-m, J. Arnaud, J. De-leiris, and . Favier-a, Effects of adriamycin on chronic cardiotoxicity in selenium-deficient rats

, Basic Research in Cardiology, vol.87, pp.173-183, 1992.

, Scientific Affairs. Effect of toxic chemicals on the reproductive system

, JAMA, vol.253, pp.3431-3437, 1985.

-. Bobin, J. Y. Rancherre, and J. Y. Mayer-m,

, Accidents d 1 extravasation des chimiothérapies anticancéreuses

, Conc. Med, vol.109, issue.31, pp.2862-2867, 1987.

-. D. Rubinow-d, M. Z. Papa, C. Simpson, C. A. Seipp, M. T. Lotze et al., The neuropsychiatrie effects of treatment with interleukin-2 and LAK cells

, Ann. Inter. Med, vol.107, pp.293-300, 1987.

-. Ballentine-r, Practical consideratlons in the preparation and administration of cancer chemotherapy

, Am. J. 1. V. Therap. Clin. Nutr, pp.6-15, 1983.

-. M. Marty-m, Ondansétron : nouvel antiémétique de référence

, Cahiers Cancer, pp.23-26, 1991.

-. and C. M. , 5-fluorouracil associated cardiotoxicity, Cancer, pp.1-36, 1988.

-. H. , L'immunothérapie des cancers

-. Hochstein-p, Generation of free radicals and lipid peroxidation by redox cycling of adriamycin and daunomycin. Biochemical and biophysical research communications, vol.77, pp.797-803, 1977.

-. , An outline of anti-emetic treatment

, Eur. J. Cancer Clin. Oncol, pp.7-11, 1989.

, Subcell Biochem, vol._lA, pp.363-378, 1989.

-. De-pracontal-m,

L. Le, , p.64, 1991.

-. Gutteridge and J. M. , Oxygen toxicity, oxygen radicals, transition metals and disease, Biochem. J, vol.219, pp.1-14, 1984.

-. B. , Self-reductlon of the Iron (Ill) -doxorubicin complex

, 32 -HAWTHORN J. The physiological basis of chemotherapy-induced emesis, Clinician, pp.14-20, 1988.

-. J. Gandara and D. R. , Serotonin antagonists: a new class of antiemetic agents, J. Natl. Cancer lnst, vol.83, pp.613-620, 1991.

. -hoerni-b, Relation médecin-malade et décision en cancérologie, Bull.Cancer, vol.74, pp.307-312, 1987.

-. ,

A. .. Brand-b, . S. Buser-k, and . Cerny-t, The symptomatic control of cytostatic drug-induced emesls. A recent history review

, Eur. J. Cancer, pp.2-8, 1990.

-. Kvaloy, S. Dicato, and M. A. , A comparison of ondansetron with metoclopramide in the prophylaxis of chemotherapy-induced nausea and vomiting-A randomize doubleblind study

, Eur. J. Cancer, vol.26, pp.311-314, 1990.

-. Howell-s.-b,

, Multivesicular Liposomes Containing Cytarabine for Slow-Release SC Administration, Cancer Treatment Reports, issue.5, pp.447-450, 1987.

-. , K. D. , and ,. B. Howell-s, Modulation of the peritoneal clearance of liposomal cytosine arabinoside by blank liposomes, Cancer Chemotherapy and Pharmacology, vol.2, issue.4, pp.307-310, 1987.

-. Ueno, N. Tajano, M. Yabushita, H. Noguchi, M. Ishirara et al., Effect of Adrlamycin Entrapped by Sulfatide-Contalning Liposomes on Ovarlan Tumor-Bearing Nude Mice

, Biotechnology and supplied biochemistry, issue.5, pp.471-478, 1986.

, La Recherche, vol.20, issue.212, pp.904-913, 1989.

-. S. Lucas-v and . Pharm-b.-s, Emesis as a critical problem in chemotherapy

, N. Engl. J. Med, vol.305, pp.948-949, 1981.

-. E. Lotze, M. T. Shibber, J. M. Tucher, E. O. Bonow-r, . P. Ognibene-f et al.,

, J. Clin. Oncol, 1920.

-. D. Machy, P. Devaux, and C. Barbet-j,

, Antibody-bearing liposomes : targeting in vivo, Biology of the Cell, pp.41-111, 1983.

-. D. Hayes, J. D. Wolf, and C. R. , Glutathione and glutathione-dependent enzymes in ovarian adenocarcinoma cell lines derived from a patient before and after the onset of drug resistance

, Carcinogenesis, vol.2, issue.7, pp.1283-1287, 1988.

-. Lopez, G. Berenstein, . L. Hopfer-r, . Mehta-r, H. E. Mehta-k et al.,

, Liposome-encapsulated amphotericin B for treatment of disseminated candidiasis in neutropenic mice

, J. Infect. Dis, vol.150, pp.278-283, 1984.

-. Pelegrin-a and . Buchegger-f, lmaging and therapy with monoclonal antibodies in non-hematopoietic tumors

, Current Opinion in lmmunology, pp.685-693, 1991.

-. Kadouche-j, Tests rapides et anticorps monoclonaux

, Tempo Médical, vol.222, pp.5-14, 1986.

C. Milstein and . Antibodies,

, Scientific American, vol.243, issue.4, pp.66-76, 1990.

-. R. Leventhal, H. V. Easterling-d, and . R. Love-r, Anxiety and drug tast as predictors of anticipatory nausea in cancer chemotherapy

, J. Clin. Oncol, vol.4, pp.224-233, 1986.

-. Douches, S. Oppenheim, and J. J. ,

, J. lmmunol, vol.136, pp.1483-2485, 1988.

-. Keizer and H. J. , Psychologie aspects of the treatment of emesis in cancer nursing

, Sernin. in Oncol. Nurs, pp.6-9, 1990.

. -parinaud-f, Cancer : pousser les cellules malignes au suicide

. Bien-etre and . Santé, , vol.87, p.6, 1991.

D. J. -rion, M. Jacquot, H. Fessi, F. Puisieux, and . Potier-p, Effects of free and liposome encapsulated taxol on two brain tumors xenografted into nude mice, vol.6, pp.23-28, 1992.

M. Samoun, . C. Potocka-a, . Pilliere-r, . Delorme-g, J. Prinseau et al.,

. La-presse-médicale, , vol.20, pp.458-460, 1991.

-. Sanson, C. Guerin, and J. C. La-photochimiothérapie,

, La Revue du Praticien-Médecine Générale, issue.172, p.715, 1992.

-. M. Crost and S. Tocanne-j.-f, Inhibition of tumor cell growth in vitro and in vivo by 2-methyl 9-hydroxyellipticinium entrapped within phospholipid vesicles. Biopharmaceutics and drug disposition, vol.1, pp.357-371, 1986.

. Schneider-m, Incidence of delayed cisplatin-induced emesis following acute antiemetic prophylaxis with granisetron-An historical review, Advances in emetic control, pp.19-21, 1990.

-. , P. Coune, A. Brassinne, and L. C. Hollaert-c,

, Médecine/sciences, pp.41-44, 1987.

-. , The control of chemotherapy-induced emesis

, Ann. int. Med, vol.95, pp.352-359, 1981.

-. Foon and K. A. , Overview of Monoclonal Antibodies in the Diagnosis and Therapy of Cancer

, Cancer Investigation, vol.2, issue.2, pp.195-209, 1991.

. M. Wilcox-p, J. H. Fetting, . M. Nettesheim-k, and M. D. Abeloff, Anticipatory vomiting in women receiving cyclophosphamide, methotrexate and 5-FU (CMF) adjuvant chemotherapy for breast carcinoma, Cancer Treat. Rep, vol.66, pp.1601-1604, 1982.

-. K. Hirch and M. S. , Herpes virus infection in patients with neoplastic disease

, Am. J. Med, vol.76, pp.464-478, 1984.

. -zittoun-r,

, Considérations théoriques sur la qualité de vie des cancéreux traités, Bordeaux Med, pp.577-580, 1984.

, LA CHIMIOTHERAPIE 1.1) GENERALITES

L. Divers and . De-toxicites, 1) LES TOXICITES AIGUES 1.2.1. l) LA TOXICITE HEMATOLOGIQUE 1.2.1.2) LA TOXICITE LYMPHOIDE ET

L. De, IMMUNOSUPPRESSION 1.2.2.3) LA TOXICITE DIGESTIVE 1.2.2.4) LA TOXICITE CUTANEE ET DES PHAN ERES 1.2.2.5) LA TOXICITE RENALE 1.2.2.6) LA TOXICITE CARDIAQUE 1.2.2. 7) LA NEUROTOXICITE-1.2.2.8) LA TOXICITE HEPATIQUE 1.2.2.9) LA TOXICITE PULMONAIRE 1.2 2.9.1) LES SURINFECTIONS PULMONAIRES 1.2.2.9.2) LES INFILTRATS, vol.38, p.39
URL : https://hal.archives-ouvertes.fr/hal-00875126

L. Femme, , vol.47, p.48

L. Toxicite,

, LES ORGANOPLATINES 1.3.1.7.l) CISPLATINE (CISPLATINE R, CISPLATYLR ) 1.3.1.7.2) CARBOPLATINE (PARAPLATINE R )

, LES ANTIPYRIMIDIQUES 1.3.3.2.1) 5-FLUORO-URACILE (FLUORO-URACILE R ) 1.3.3.2.2) CYTARABINE (ARACYTINE R , CYTARBELR )

, LES AUTRES ANTIBIOTIQUES 1.3.5.1.1) BLEOMYCINE (BLEOMYCINE R ) 1

, LES AUTRES AGENTS ANTICANCEREUX, vol.1

L. Chimiotherapie,

L. Canc, ERS 1.5.1) LES CORRECTIONS DES TROUBLES NUTRITIONNELS ET DIGESTIFS 1.5.1.1) LES SOINS BUCCO-DENTAIRES

L. A. Manipulation, E. Medicaments-anticancereux-;-les-produlls, and . Manipulation,

, LES ANDROGENES 11.1.5) L'ASSOCIATION HORMONE-CYTOTOXIQUE 11. l .5. l) ESTRAMUSTINE CESTRACYTR) 11.1.5.2) PREDNIMUSTINE CSTEREOCYTR )

, ANTl-GLUCOCORTICOIDES 11.2.2) LES ANTl-OESTROGENES 11.2.3) LES ANTl-ANDROGENES 11.2.3.1) CYPROTERONE ACETATE (ANDROCURR ) 11.2.3.2) FLUT AMIDE (EULEXINE R ), LES ANTl-HORMONES 11.2.1) LES

L. De-l, AROMATASEl, vol.12, p.115

L. Gnrh,

L. De-l'hormone,

D. Experience-a-l'hopital,

. Les and . De, CANCERS

L. Effels, S. Le, . Sanguin, . Et, and . Le-taux, 1) LE CISPLATINE 11. l.1) LA TOXICITE RENALE 11. l .2) LES MODIFICATIONS MORPHOLOGIQUES ET CHIMIQUES AU NIVEAU DU REIN ll.1.3), vol.11

, LA PROTECTION 11.1.5.1) L'HYDRATATION ET LES DIURETIQUES 11.1.5.2) LES COMPOSES SOUFRES

). Ill, U. Etude-d-1, and . Anticancereuse,

L. E. Probleme, . Nausees, . Vomissements, . Iv, . Variation et al., 2.1) LA ZONE CHEMORECEPTIVE IV.2.2) LES VOIES AFFERENTES IV.2.3) LES CENTRES SUPERIEURS CORTICAUX

U. Iv,

U. Iv, , vol.6